ImmunoGen, Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (30)

Latest Posts

About This Stock More About This Stock
Bulls And Bears Of The Week: Apple, Chevron, FedEx, Uber And More
Article By: Benzinga
Sunday, May 19, 2019 5:07 AM EDT
The escalating trade war with China continued to overshadow the markets in the past week. Investors also saw mixed economic numbers, as well as positive surprises in quarterly reports and initial public offerings, and bad news for a market darling.
In this article: FDX, JNJ, ARRY, IMGN, AAPL, LYFT, UBER, GOOGL, CVX
Read
ImmunoGen - Chart Of The Day
Article By: Jim Van Meerten
Friday, February 2, 2018 7:35 PM EDT
The Chart of the Day belongs to ImmunoGen, which develops pharmaceuticals, primarily for the treatment of cancer. Its product candidates are called tumor-activated prodrugs and are based on its proprietary immunoconjugate technology platform.
In this article: IMGN
Read
ImmunoGen
Article By: Tim Knight
Tuesday, July 11, 2017 4:06 PM EDT
So far, IMGN it’s giving me weak results.
In this article: IMGN
Read
5 Top Performing Stocks Of The Top ETF Of 2015
Article By: Sweta Killa
Monday, December 28, 2015 1:22 PM EDT
We have highlighted five best performing stocks in the ETF with their respective positions in the fund’s basket: ANAC, DYAX, RARE, IMGN and SBIO.
In this article: ANAC, DYAX, IMGN, SHPG, SBIO, RARE
Read
5 Healthy Stocks In The Top Biotech ETF
Article By: Zacks Investment Research
Wednesday, June 17, 2015 1:42 PM EDT
The pharma stocks are soaring, but the biotech is the real winner, having emerged as a leader yet gain in the health care world and the broader market from the year-to-date look.
In this article: ANAC, GEVA, HALO, HZNP, IMGN Also: SBIO
Read

PARTNER HEADLINES

Latest Tweets for $IMGN

No tweets yet!